[HTML][HTML] The worldwide clinical trial research response to the COVID-19 pandemic-the first 100 days
Background: Never before have clinical trials drawn as much public attention as those
testing interventions for COVID-19. We aimed to describe the worldwide COVID-19 clinical …
testing interventions for COVID-19. We aimed to describe the worldwide COVID-19 clinical …
Perspectives on the use and risk of adverse events associated with cytokine-storm targeting antibodies and challenges associated with development of novel …
AM Johnson, R Barigye… - Human Vaccines & …, 2021 - Taylor & Francis
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent
of the novel coronavirus disease 2019 (COVID-19) pandemic that lacks globally accessible …
of the novel coronavirus disease 2019 (COVID-19) pandemic that lacks globally accessible …
Estimating the effect of COVID-19 on trial design characteristics: a registered report
There have been reports of poor-quality research during the COVID-19 pandemic. This
registered report assessed design characteristics of registered clinical trials for COVID-19 …
registered report assessed design characteristics of registered clinical trials for COVID-19 …
regCOVID: Tracking publications of registered COVID-19 studies
CS Mayer, V Huser - BMC Medical Research Methodology, 2022 - Springer
Background In response to the COVID-19 pandemic many clinical studies have been
initiated leading to the need for efficient ways to track and analyze study results. We …
initiated leading to the need for efficient ways to track and analyze study results. We …
[PDF][PDF] The worldwide clinical trial research response to the COVID-19 pandemic-the first 100 days [version 2; peer review
Background: Never before have clinical trials drawn as much public attention as those
testing interventions for COVID-19. We aimed to describe the worldwide COVID-19 clinical …
testing interventions for COVID-19. We aimed to describe the worldwide COVID-19 clinical …